Ascertaining Medication Use and Patient-Reported Outcomes via an App and Exploring Gamification in Patients With Multiple Sclerosis Treated With Interferon β-1b: Observational Study

BACKGROUND: The BETACONNECT autoinjector and myBETAapp app were designed to support patients with multiple sclerosis receiving interferon β-1b and are an ideal platform for digital observational studies. A recent pilot study in Germany demonstrated the feasibility of using the app to recruit patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Limmroth, Volker, Bayer-Gersmann, Kirsten, Mueller, Christian, Schürks, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929528/
https://www.ncbi.nlm.nih.gov/pubmed/35285806
http://dx.doi.org/10.2196/31972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929528/
https://www.ncbi.nlm.nih.gov/pubmed/35285806
http://dx.doi.org/10.2196/31972

Ejemplares similares